Kinepolis Group: Publication of a transparency notification

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
125
Kinepolis Group: Publication of a transparency notification

(Article 14, first paragraph, of the law of 2 may 2007 on disclosure of major holdings)

Press release Regulated information

12 May 2017, 17h45

On 9 May 2017, Kinepolis Group NV has received a transparency notification from BlackRock Inc., indicating that: 

  • by virtue of transactions in shares, BlackRock Inc. has fallen below the threshold of 3% of the voting rights attached to shares of Kinepolis Group NV;
  • by virtue of transactions in equivalent financial instruments, BlackRock Inc. has crossed the threshold of 3% of the voting rights attached to equivalent financial instruments.

Notification details:

Notification date:                                  9 May 2017

Transaction date:                                  8 May 2017

Relevant threshold:                               3%

Notification by :

BlackRock, Inc. 55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock (Netherlands) B.V. Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock Advisors (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Asset Management Canada Limited 161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Fund Advisors 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National Association 400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock International Limited Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K.
BlackRock Investment Management (Australia) Limited Level 37, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 Australia
BlackRock Investment Management (UK) Limited 12 Throgmorton Avenue, London, EC2N 2DL, U.K.

            Voting rights and equivalent financial instruments:

A) Voting rights Previous notification After the transaction
  # of voting rights # of voting rights % of voting rights
Holders of voting rights   Linked to securities Not linked to the securities Linked to securities Not linked to the securities
BlackRock, Inc. 0 0   0.00%  
BlackRock (Netherlands) B.V. 2 056 2 056   0.01%  
BlackRock Advisors (UK) Limited 10 701 13 546   0.05%  
BlackRock Asset Management Canada Limited 935 935   0.00%  
BlackRock Fund Advisors 104 533 116 523   0.43%  
BlackRock Institutional Trust Company, National Association 29 190 48 605   0.18%  
BlackRock International Limited 44 006 54 664   0.20%  
BlackRock Investment Management (Australia) Limited 124 124   0.00%  
BlackRock Investment Management (UK) Limited 630 558 75 993   0.28%  
Subtotal 822 103 312 446   1.14%  
TOTAL   312 446 0 1.14% 0.00%

  

B) Equivalent financial instruments After the transaction
Holders of equivalent financial instruments Type of financial instrument Expiration date Exercise period or date # of voting rights that may be acquired if the instrument is exercised % of voting rights Settlement
BlackRock Advisors (UK) Limited Securities Lent     10 172 0.04% physical
BlackRock Fund Advisors Securities Lent     2 722 0.01% physical
BlackRock Institutional Trust Company, National Association Securities Lent     31 567 0.12% physical
BlackRock Investment Management (UK) Limited Securities Lent     609 197 2.23% physical
BlackRock Institutional Trust Company, National Association Contract for Difference     5 749 0.02% cash
BlackRock Investment Management (UK) Limited Contract for Difference     257 316 0.94% cash
TOTAL       916 723 3.35%  
TOTAL (A & B)         # of voting rights % of voting rights
      1,229,169 4.49%

   The chain of controlled companies in which shares are actually held, is included in the aforementioned notification which can be consulted, together with this regulated release, on the website of Kinepolis Group via this link .

Total capital Kinepolis Group NV: 18,952,288.41 EUR Number of securities with voting rights in Kinepolis Group NV: 27,365,197 Number of voting rights in Kinepolis Group NV: 27,365,197 In Article 8 of the Articles of Association of Kinepolis Group NV, the notification thresholds were fixed at 3%, 5% and multiples of 5%.

Contact

Kinepolis Investor Relations +32 (0)9 241 00 22 investor-relations@kinepolis.com

About Kinepolis

Kinepolis Group NV was formed in 1997 as a result of the merger of two family cinema groups and was listed on the stock exchange in 1998. Kinepolis offers an innovative cinema concept which serves as a pioneering model within the industry. Kinepolis has a chain of 49 cinemas spread across Belgium, the Netherlands, France, Spain, Luxembourg, Switzerland and Poland. Apart from its cinema activities, the Group also operates in film distribution, event organization, screen publicity and property management. 2,300 employees are committed to providing millions of cinema visitors an unforgettable movie experience.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Sojo Industries Partners with Molex to Enhance Supply Chain Tracking

Updated Category News Views 270

Sojo Industries Collaborates with Molex for Innovation Sojo Industries is making waves in the smart supply chain market with its latest collaboration with Molex. This partnership aims to elevate the production capabilities of the Sojo Seal™, an advanced device designed for tracking consumer-packaged goods. By enhancing supply chain transparency, this collaboration...

Continue Reading
Exploring the Driving Forces Behind Biodegradable Plastics Growth

Updated Category News Views 37

Understanding the Biodegradable Plastics Market As the world leans towards sustainability, the biodegradable plastics market is witnessing an impressive transformation. It is projected to reach USD 28.7 billion, showcasing a remarkable compound annual growth rate of 15.2% from 2024 to 2032. This shift is mainly driven by our collective concern over plastic waste and its...

Continue Reading
Securing Justice: ALLR Investors Unite for Legal Action

Updated Category News Views 50

Opportunity for Investors to Lead Legal Action Investors holding securities of Allarity Therapeutics, Inc. (NASDAQ: ALLR) now have a significant opportunity to join a legal action concerning alleged securities fraud. The Schall Law Firm, which represents investors in shareholder rights litigation, has announced a class action lawsuit aimed at seeking justice and recovery...

Continue Reading
Unlocking Monthly Income from HPQ Stock: A Guide

Updated Category News Views 134

Understanding HP Inc. and Its Dividend Potential HP Inc. (NYSE: HPQ) is on the verge of announcing its fourth-quarter earnings, generating buzz among investors. With analysts predicting earnings of approximately 92 cents per share, down slightly from 93 cents last year, the interest in HPQ is palpable. The expected quarterly revenue stands at a robust $14.49 billion, an...

Continue Reading
Upcoming Extraordinary General Meeting for RomReal: Key Details

Updated Category News Views 64

Overview of RomReal's Extraordinary General Meeting RomReal is gearing up for an Extraordinary General Meeting, which is important for both shareholders and potential investors. This gathering will provide stakeholders with a chance to engage with the company’s management and discuss its strategic path ahead. Purpose of the Extraordinary General Meeting The main goal of...

Continue Reading